Urocortin II induces nitric oxide production through cAMP and Ca 2+ related pathways in endothelial cells

Cellular Physiology and Biochemistry

Volumn 23, Issue 1-3, 2009, Pages 87-96

  Grossini, Elena ^a,b   Molinari, Claudio ^a   Mary, David A S G ^a   Uberti, Francesca ^a   Ribichini, Flavio ^a   Caimmi, Philippe Primo ^a   Vacca, Giovanni ^a  

^a UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

Endothelial cells; Nitric Oxide; Urocortin II

Indexed keywords

2',5' DIDEOXYADENOSINE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ASTRESSIN; ASTRESSIN 2B; CALCIMYCIN; CALCIUM; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; CYCLIC AMP; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FORSKOLIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PROTEIN KINASE B; UNCLASSIFIED DRUG; UO 126; UROCORTIN II; WORTMANNIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SWINE; WESTERN BLOTTING;

SUIDAE; SUS;

EID: 60549098256     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000204097     Document Type: Article

References (52)

1. Pearson D, Shively JE, Clark BR, Geschwind II, Barkley M, Nishioka RS, Bern HA: Urotensin II: a somatostatin-like peptide in the caudal neurosecretory system of fishes. Proc Natl Acad Sci U S A 1980;77:5021-5024.
2. Erspamer V, Erspamer GF, Improta G, Negri L, de Castiglione R: Sauvagine. A new polypeptide from Phyllomedusa sauvagei skin. Occurrence in various Phyllomedusa species and pharmacological actions on rat blood pressure and diuresis. Naunyn Schmiedebergs Arch Pharmacol 1980;312:265-270.
3. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesch JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE: Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 2001;98:2843-2848.
4. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fischer W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW: Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci U SA 2001;98:7570-7575.
5. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale W: Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 1994;91:8777-8781.
6. Hauger RL, Grigoriadis DE, Dallman MF, Plotsky PM, Vale WW Dautzenberg FM: International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotrophin-releasing factor and their ligands. Pharmacol Rev 2003;55:21-26.
7. Kimura Y, Takahashi K, Totsune K, Muramatsu Y, Kaneko C, Darnel AD, Suzuki T, Ebina M, Nukiwa T, Sasano H: Expression of urocortin and corticotropin-releasing factor receptor subtypes in the human heart. J Clin Endocrinol Metab 2002; 87:340-346.
8. Oki Y, Sasano H: Localization and physiological roles of urocortin. Peptides 2004;25:1745-1749.
9. Burnett JC Jr: Urocortin: advancing the neurohumoral hypothesis of heart failure. Circulation 2005;112:3544-3546.
10. Nishikimi T, Miyata A, Horio T, Yoshihara F, Nagaya N, Takishita S, Yutani C, Matsuo H, Matsuoka H, Kangawa K: Urocortin, a member of the corticotropin-releasing factor family, in normal and diseased heart. Am J Physiol Heart Circ Physiol 2000; 279:H3031-H3039.
11. Charles CJ, Rademaker MT, Richards AM: Urocortins: putative role in cardiovascular disease. Curr Med Chem Cardiovasc Hematol Agents 2004;2:43-47.
12. Parkes DG, Vaughan J, Rivier J, Vale W, May CN: Cardiac inotropic actions of urocortin in conscious sheep. Am. J. Physiol 1997;272:H2115-H2122.
13. Brar BK, Jonassen AK, Stephanou A, Santilli G, Railson J, Knight RA, Yellon DM, Latchman DS: Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway. J Biol Chem 2000;275:8508-8514.
14. Yang LZ, Kockskämper J, Heinzel FR, Hauber M, Walther S, Spiess J, Pieske B: Urocortin II enhances contractility in rabbit ventricular myocytes via CRF(2) receptor-mediated stimulation of protein kinase A. Cardiovasc Res. 2006;69:402-411.
15. Rademaker MT, Cameron AC, Charles CJ, Richards AM: Integrated hemodynamic, hormonal and renal actions of urocortin 2 in normal and paced sheep: beneficial effects in heart failure. Circulation 2005;112:3624-3632.
16. Schilling L, Kanzler C, Schmiedek P, Ehrenreich H: Characterization of the relaxant action of urocortin, a new peptide related to corticotropin- releasing factor in the rat isolated basilar artery. Br J Pharmacol 1998; 125:1164-1171.
17. Huang Y, Chan FL, Lau CW, Tsang SY, He GW, Chen ZY, Yao X: Urocortin-induced endothelium-dependent relaxation of rat coronary artery: role of nitric oxide and K+ channels. Br J Pharmacol 2002;135:1467-1476.
18. Chen ZW, Huang Y, Yang Q, Li X, Wei W, He GW: Urocortin-induced relaxation in the human internal mammary artery. Cardiovasc Res 2005;65:913-920.
19. Grossini E, Molinari C, Mary DA, Marino P, Vacca G: The effect of urocortin II administration on the coronary circulation and cardiac function in the anesthetized pig is nitric-oxide-dependent. Eur J Pharmacol 2008;578:242-248.
20. Fleming I, Fisslthaler B, Dimmeler S, Kemp BE, Busse R: Phosphorylation of Thr495 regulates Ca2+/calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res 2001;88:E68-E75.
21. Michell BJ, Griffiths JE, Mitchelhill KI, Rodriguez-Crespo I, Tiganis T, Bozinovski S, de Montellano PR, Kemp BE, Pearson RB: The Akt kinase signals directly to endothelial nitric oxide synthase. Curr Biol 1999;9:845-848.
22. Michell BJ, Harris MB, Chen ZP, Ju H, Venema VJ, Blackstone MA, Huang W, Venema RC, Kemp BE: Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635. J Biol Chem 2002;277:42344-42351.
23. Fulton D, Gratton JP, McCabe TJ, Fontana J, Fujio Y, Walsh K, Franke TF, Papapetropoulos A, Sessa WC: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature (London) 1999;399:597-601.
24. Mount PF, Kemp BE, Power DA: Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J Mol Cell Cardiol. 2007;42:271-279.
25. John TA, Ibe BO, Raj JU: Regulation of endothelial nitric oxide synthase: involvement of protein kinase G 1 beta, serine 116 phosphorylation and lipid structures. Clin Exp Pharmacol Physiol 2007;35:148-158.
26. Chen DB, Bird IM, Zheng J, Magness RR: Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology 2004;145:113-125.
27. Lantin-Hermoso RL, Rosenfeld CR, Yuhanna IS, German Z, Chen Z, Shaul PW: Estrogen acutely stimulates nitric oxide synthase activity in fetal pulmonary artery endothelium. Am J Physiol 1997;273:L119-L126.
28. Wei Z, Al-Mehdi AB, Fisher AB: Signaling pathway for nitric oxide generation with simulated ischemia in flow-adapted endothelial cells. Am J Physiol Heart Circ Physiol 2001;281:H2226-H2232.
29. Zou MH, Hou XY, Shi CM, Nagata D, Walsh K, Cohen RA: Modulation by peroxynitrite of Akt- and AMP-activated kinase-dependent Ser1179 phosphorylation of endothelial nitric oxide synthase. J Biol Chem 2002;277:32552-32557.
30. Mount PF, Hill RE, Fraser SA, Levidiotis V, Katsis F, Kemp BE, Power DA: Acute renal ischemia rapidly activates the energy sensor AMPK but does not increase phosphorylation of eNOS-Ser1177. Am J Physiol Renal Physiol 2005;289:F1103-F1115.
31. Marín J, Sánchez-Ferrer CF: Role of endothelium-formed nitric oxide on vascular responses. Gen Pharmacol 1990;21:575-587
32. Molinari C, Grossini E, Mary DA, Uberti F, Ghigo E, Ribichini F, Surico N, Vacca G: Prolactin induces regional vasoconstriction through the beta2-adrenergic and nitric oxide mechanisms. Endocrinology 2007;148:4080-4090.
33. Grossini E, Molinari C, Mary DA, Uberti F, Caimmi PP, Surico N, Vacca G: Intracoronary genistein acutely increases coronary blood flow in anesthetized pigs through beta-adrenergic mediated nitric oxide release and estrogenic receptors. Endocrinology 2008;149:2678-2687.
34. Kimura C, Oike M, Ohnaka K, Nose Y, Ito Y: Constitutive nitric oxide production in bovine aortic and brain microvascular endothelial cells: a comparative study. J Physiol 2004;554:721-730.
35. Heldwein KA, Redick DL, Rittenberg MB, Claycomb WC, Stenzel-Poore MP: Corticotropin-releasing hormone receptor expression and functional coupling in neonatal cardiac myocytes and AT-1 cells. Endocrinology 1996;137:3631-3639.
36. Brar BK, Stephanou A, Knight R, Latchman DS: Activation of protein kinase B/Akt by urocortin is essential for its ability to protect cardiac cells against hypoxia/reoxygenation-induced cell death. J Mol Cell Cardiol 2002;34:483-492.
37. Kageyama K, Furukawa K, Miki I, Terui K, Motomura S, Suda T: Vasodilative effects of urocortin II via protein kinase A and a mitogen-activated protein kinase in rat thoracic aorta. J Cardiovasc Pharmacol 2003;42:561-565.
38. Schneider JC, El Kebir D, Chéreau C, Lanone S, Huang XL, De Buys Roessingh AS, Mercier JC, Dall'Ava-Santucci J, Dinh-Xuan AT: Involvement of Ca2+/ calmodulin-dependent protein kinase II in endothelial NO production and endothelium-dependent relaxation. Am J Physiol Heart Circ Physiol 2003;284:H2311-H2319.
39. Li H, Burkhardt C, Heinrich UR, Brausch I, Xia N, Förstermann U: Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells. Circulation 2003; 107:2348-2354.
40. Sheng JZ, Arshad F, Braun JE, Braun AP: Estrogen and the Ca2+-mobilizing agonist ATP evoke acute NO synthesis via distinct pathways in an individual human vascular endothelium-derived cell. Am J Physiol Cell Physiol 2008;294:C1531-C1541
41. Sheng JZ, Ella S, Davis MJ, Hill MA, Braun AP: Openers of SKCa and IKCa channels enhance agonist-evoked endothelial nitric oxide synthesis and arteriolar vasodilation. FASEB J 2008 in press
42. Wu Y, Hu J, Zhang R, Zhou C, Xu Y, Guan X, Li S: Enhanced intracellular calcium induced by urocortin is involved in degranulation of rat lung mast cells. Cell Physiol Biochem 2008;21:173-182.
43. Kageyama K, Kimura R, Suga S, Ogawa Y, Suda T, Wakui M: Modulation of Ca2+ influx by corticotropin-releasing factor (CRF) family of peptides via CRF receptors in rat pancreatic beta-cells. Peptides 2006;27:1814-1819.
44. Scarabelli TM, Pasini E, Stephanou A, Comini L, Curello S, Raddino R, Ferrari R, Knight R, Latchman DS: Urocortin promotes hemodynamic and bioenergetic recovery and improves cell survival in the isolated rat heart exposed to ischemia/reperfusion. J Am Coll Cardiol 2002;40:155-161.
45. Rademaker MT, Charles CJ, Espiner EA, Fisher S, Frampton CM, Kirkpatrick CM, Lainchbury JG, Nicholls MG, Richards AM, Vale WW: Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep. J Am Coll Cardiol 2002;40:1495-1505.
46. Brar BK, Jonassen AK, Egorina EM, Chen A, Negro A, Perrin MH, Mjøs OD, Latchman DS, Lee KF, Vale W: Urocortin-II and Urocortin-III are cardioprotective against ischemia reperfusion injury: an essential endogenous cardioprotective role for corticotrophin releasing factor receptor type 2 in the murine heart. Endocrinology 2004;145:24-35.
47. Mackay KB, Stiefel TH, Ling N, Foster AC: Effects of a selective agonist and antagonist of CRF2 receptors on cardiovascular function in the rat. Eur J Pharmacol 2003;469:111-115.
48. Ikeda K, Tojo K, Otsubo C, Udagawa T, Hosoya T, Tajima N, Nakao K, Kawamura M: Effects of urocortin II on neonatal rat cardiac myocytes and nonmyocytes. Peptides 2005;26:2473-2481.
49. Sanz E, Monge L, Fernández N, Climent B, Diéguez G, Garcia-Villalón AL: Mechanisms of relaxation by urocortin in renal arteries from male and female rats. Br J Pharmacol 2003;140:1003-1007.
50. Arnal JF, Dinh-Xuan AT, Pueyo M, Darblade B, Rami J: Endothelium-derived nitric oxide and vascular physiology and pathology. Cell Mol Life Sci 1999;55:1078-1087.
51. Harada M, Itoh H, Nakagawa O, Ogawa Y, Miyamoto Y, Kuwahara K, Ogawa E, Igaki T, Yamashita J, Masuda I, Yoshimasa T, Tanaka I, Saito Y, Nakao K: Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation 1997;96:3737-3744.
52. Honjo T, Inoue N, Shiraki R, Kobayashi S, Otsui K, Takahashi M, Hirata K, Kawashima S, Yokozaki H, Yokoyama M: Endothelial urocortin has potent antioxidative properties and is upregulated by inflammatory cytokines and pitavastatin. J Vasc Res 2006;43:131-138.